Editorial: SARS-CoV-2 in neurodegenerative diseases

• Gonzalo Emiliano Aranda-Abreu,
• Alfonso Carreón-Rodriguez,
• Sonia Zuñiga,
• David Pozo

Affiliations

Gonzalo Emiliano Aranda-Abreu

Instituto de Investigaciones Cerebrales, Universidad Veracruzana, Xalapa, Mexico

Alfonso Carreón-Rodriguez

Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico

Sonia Zuñiga

National Center for Biotechnology, Spanish National Research Council (CSIC), Madrid, Spain

David Pozo

Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, University of Seville, Seville, Spain